Advertisement
Screener

BioLife Solutions, Inc. (BLFS) Proceeds from Issuance of Debt

2.4 / 5 stars · 45/93 Roast Me

BioLife Solutions, Inc. Proceeds from Issuance of Debt

BioLife Solutions, Inc. (BLFS) reported Proceeds from Issuance of Debt of $2.17 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-09.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfDebt · last filed 2020-11-09

  • BioLife Solutions, Inc. proceeds from issuance of debt for the quarter ending 2020-09-30 was $0.00.
  • BioLife Solutions, Inc. proceeds from issuance of debt for the quarter ending 2019-09-30 was $0.00.
Period endProceeds from Issuance of Debt 3 monthProceeds from Issuance of Debt 6 monthProceeds from Issuance of Debt 9 month
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$2.17M
10-Q · filed 2020-11-09
2020-06-30$2.17M
10-Q · filed 2020-08-10
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
2019-06-30$0.00
10-Q · filed 2020-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Axogen, Inc. (AXGN)United States$2.329B-73.83
CONMED Corp (CNMD)United States$1.353B26.72
Ceribell, Inc. (CBLL)United States$0.916B-11.27
TransMedics Group, Inc. (TMDX)United States$2.911B15.17
CapsoVision, Inc (CV)United States$0.310B-12.68
Electromed, Inc. (ELMD)United States$0.233B31.13
EDAP TMS SA (FOCL)$0.171B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Vivani Medical, Inc. (VANI)United States$0.111B
electroCore, Inc. (ECOR)United States$0.102B